208 related articles for article (PubMed ID: 26471735)
1. Successful use of high-dose cytarabine in a patient with acute myeloid leukemia and severe hepatic dysfunction.
Barker JA; Marini BL; Bixby D; Perissinotti AJ
J Oncol Pharm Pract; 2016 Dec; 22(6):811-815. PubMed ID: 26471735
[TBL] [Abstract][Full Text] [Related]
2. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940
[TBL] [Abstract][Full Text] [Related]
3. Cytarabine dose for acute myeloid leukemia.
Löwenberg B; Pabst T; Vellenga E; van Putten W; Schouten HC; Graux C; Ferrant A; Sonneveld P; Biemond BJ; Gratwohl A; de Greef GE; Verdonck LF; Schaafsma MR; Gregor M; Theobald M; Schanz U; Maertens J; Ossenkoppele GJ;
N Engl J Med; 2011 Mar; 364(11):1027-36. PubMed ID: 21410371
[TBL] [Abstract][Full Text] [Related]
4. Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis.
Sancho JM; Deben G; Parker A; Piñana JL; Bolam S; Sánchez-García E; Giménez E; Pascual T; Fernández-Abellán P; Palomera L; Ribera JM
Int J Hematol; 2007 Jul; 86(1):33-6. PubMed ID: 17675264
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of congenital acute myeloid leukemia (AML-M6) in a premature infant.
van Dongen JC; Dalinghaus M; Kroon AA; de Vries AC; van den Heuvel-Eibrink MM
J Pediatr Hematol Oncol; 2009 Nov; 31(11):853-4. PubMed ID: 19779381
[TBL] [Abstract][Full Text] [Related]
6. Cytarabine dose for acute myeloid leukemia.
Mori J; Tsubokura M; Kami M
N Engl J Med; 2011 Jun; 364(22):2166-7; author reply 2168-9. PubMed ID: 21631342
[No Abstract] [Full Text] [Related]
7. Possible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemia.
Azevedo MC; Velloso ED; Buccheri V; Chamone DA; Dorlhiac-Llacer PE
Braz J Med Biol Res; 2015 Feb; 48(2):178-85. PubMed ID: 25517921
[TBL] [Abstract][Full Text] [Related]
8. Cytarabine dose for acute myeloid leukemia.
Medeiros BC; Othus M; Appelbaum FR
N Engl J Med; 2011 Jun; 364(22):2167-8; author reply 2168-9. PubMed ID: 21631340
[No Abstract] [Full Text] [Related]
9. Takotsubo cardiomyopathy after systemic consolidation therapy with high-dose intravenous cytarabine in a patient with acute myeloid leukemia.
Baumann S; Huseynov A; Goranova D; Faust M; Behnes M; Nolte F; Heidenreich D; Hofmann WK; Borggrefe M; Akin I; Klein S
Oncol Res Treat; 2014; 37(9):487-90. PubMed ID: 25231689
[TBL] [Abstract][Full Text] [Related]
10. Impact of high dose cytarabine dosing strategies in obese patients with acute myeloid leukemia.
Ochs MA; Perissinotti AJ; Marini BL; Burke PW; Bixby DL; Pettit KM; Benitez LL
Leuk Res; 2021 Mar; 102():106517. PubMed ID: 33561633
[TBL] [Abstract][Full Text] [Related]
11. [Effects of small-dose cytarabine on the course of atheromatosis in over 60 years of age patients with acute myeloblastic leukemia (description of 2 cases)].
Sokolov AN; Isaev VG; Savchenko VG
Ter Arkh; 2002; 74(12):66-7. PubMed ID: 12577846
[No Abstract] [Full Text] [Related]
12. [Efficacy and safety of induction chemotherapy consisting of anthracycline for 3 days and cytarabine for 7 days in elderly patients with acute myeloid leukemia].
Kurahashi S; Iwasaki T; Suzuki H; Sawamoto A; Sugimoto T; Narimatsu H; Adachi T; Hayakawa F; Sugiura I
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1617-21. PubMed ID: 17940376
[TBL] [Abstract][Full Text] [Related]
13. Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.
Liu J; Mi Y; Fu M; Yu W; Wang Y; Lin D; Bian S; Wang J
Am J Hematol; 2009 Jul; 84(7):422-7. PubMed ID: 19484734
[TBL] [Abstract][Full Text] [Related]
14. Cytarabine dose for acute myeloid leukemia.
Mathisen MS
N Engl J Med; 2011 Jun; 364(22):2167; author reply 2168-9. PubMed ID: 21631341
[No Abstract] [Full Text] [Related]
15. [A phase II study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia].
Miyawaki S; Mizoguchi H; Tomonaga M; Kanamaru A; Tsukagoshi S; Nakamura T; Ohashi Y; Yoshida S; Ohno R
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2229-42. PubMed ID: 9881080
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia.
Liu H; Fu R; Li L; Wang G; Song J; Ruan E; Wang H; Wu Y; Wang X; Ding K; Shao Z
Clin Drug Investig; 2017 Feb; 37(2):167-174. PubMed ID: 27722823
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic use during cytarabine consolidation in acute myeloid leukemia.
Vale CA; Egan PC; Ingham R; Farmakiotis D; Reagan JL
Ann Hematol; 2021 Jan; 100(1):79-84. PubMed ID: 32870366
[TBL] [Abstract][Full Text] [Related]
18. Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered.
Byrd JC; Dodge RK; Carroll A; Baer MR; Edwards C; Stamberg J; Qumsiyeh M; Moore JO; Mayer RJ; Davey F; Schiffer CA; Bloomfield CD
J Clin Oncol; 1999 Dec; 17(12):3767-75. PubMed ID: 10577848
[TBL] [Abstract][Full Text] [Related]
19. A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5).
Sperr WR; Piribauer M; Wimazal F; Fonatsch C; Thalhammer-Scherrer R; Schwarzinger I; Geissler K; Knöbl P; Jäger U; Lechner K; Valent P
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3965-71. PubMed ID: 15217926
[TBL] [Abstract][Full Text] [Related]
20. High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia--is more better or more of the same?
Wolach O; Itchaki G; Bar-Natan M; Yeshurun M; Ram R; Herscovici C; Shpilberg O; Douer D; Tallman MS; Raanani P
Hematol Oncol; 2016 Mar; 34(1):28-35. PubMed ID: 25689584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]